Skip to content
healthcare.dev

Repaglinide

NDC 33342-250, Repaglinide, tablet, from Macleods Pharmaceuticals Limited.

Product NDC
33342-250
Status
Listed
Labeler
Macleods Pharmaceuticals Limited
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA207209
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/33342-250 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • REPAGLINIDE2 mg/1

Pharmacologic classes

Glinide [EPC]; Potassium Channel Antagonists [MoA]

Package NDCNDC-11Package
33342-250-1133342025011100 TABLET in 1 BOTTLE (33342-250-11)
33342-250-44333420250441000 TABLET in 1 BOTTLE (33342-250-44)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/7a93246c-9323-40c4-b590-a40dcb133c8c
  • NADAC price for package 33342025011

    GET /v1/drugs/nadac/33342025011

Use it

Look up 33342-250 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/33342-250 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 33342-250. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.